Cargando…

Validation of multiplex immunofluorescence for use in analysis of tumour infiltrating lymphocytes

Detalles Bibliográficos
Autores principales:	Galetta, Henry, Mansfield, James, Richard, Byers, Oguejiofor, Kenneth K
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4652539/ http://dx.doi.org/10.1186/2051-1426-3-S2-P411

Ejemplares similares

Validation and clinical correlation of triplex CD3, CD8 and FOXP3 IHC of tumor-infiltrating lymphocytes in follicular lymphoma
por: Mansfield, James, et al.
Publicado: (2014)

Comparison of multiplex, ELISA and immunofluorescence for detecting autoantibodies in JIA patients
por: Fawcett, Paul T, et al.
Publicado: (2012)

New method for immunoprofiling of the tumor microenvironment of cancer patients by opal multiplex quantitative immunofluorescence (IF) assay
por: Kallinteris, Nikoletta L, et al.
Publicado: (2015)

Employing multiplex immunofluorescence to quantify Her2 and phosphorylated Her2 in formalin-fixed, paraffin-embedded breast tumor specimens
por: Donovan, MJ, et al.
Publicado: (2009)

Identification of unfavourable paired cell interactions in follicular lymphoma using hypothesized interaction distribution (HID) analysis
por: Mansfield, James, et al.
Publicado: (2014)

Multiplex immunofluorescence to measure dynamic changes in tumor-infiltrating lymphocytes and PD-L1 in early-stage breast cancer
por: Sanchez, Katherine, et al.
Publicado: (2021)

Characterization and quantification of tumor infiltrating lymphocytes in breast cancer
por: Bedri, Shahinaz, et al.
Publicado: (2014)

Validation of an Accurate Automated Multiplex Immunofluorescence Method for Immuno-Profiling Melanoma
por: Yaseen, Zarwa, et al.
Publicado: (2022)

Preclinical development of tumor-infiltrating lymphocyte therapy for ovarian cancer
por: Sakellariou-Thompson, Donastas, et al.
Publicado: (2015)

Expansion and characterization of tumor-infiltrating lymphocytes from human sarcoma
por: Hall, MacLean, et al.
Publicado: (2015)

Adoptive transfer of tumor infiltrating lymphocytes for metastatic cervical cancer
por: Hinrichs, Christian S, et al.
Publicado: (2013)

Prognosis of tumor infiltrating lymphocytes in operable tongue cancer patients
por: Chen, Wan-Yu, et al.
Publicado: (2014)

P1246: CELL TYPE IDENTIFICATION USING MULTIPLEX IMMUNOFLUORESCENCE (MIF) GUIDED MACHINE LEARNING IN DLBCL
por: Chhor, Guillaume, et al.
Publicado: (2023)

Tumor-infiltrating T lymphocyte clonality predicts prognosis in human ovarian cancer
por: Tsuji, Takemasa, et al.
Publicado: (2013)

S47. Tumour infiltrating lymphocytes - a predictive marker?
por: Galon, J
Publicado: (2014)

P18. The tumour leukocyte infiltrate is the key predictor for therapeutic response to catumaxomab therapy
por: Weiler, K, et al.
Publicado: (2014)

A robust multiplex immunofluorescence and digital pathology workflow for the characterisation of the tumour immune microenvironment
por: Viratham Pulsawatdi, Amélie, et al.
Publicado: (2020)

Identification of tumor-specific T cell receptors from primary tumor-infiltrating lymphocytes
por: Kishi, Hiroyuki, et al.
Publicado: (2015)

Clinical results of combined vemurafenib and tumor-infiltrating lymphocyte therapy for metastatic melanoma
por: Sarnaik, Amod, et al.
Publicado: (2015)

Identification of mutation-specific tumor infiltrating lymphocytes from metastatic ovarian cancer
por: Deniger, Drew C, et al.
Publicado: (2015)

Generation of tumor-infiltrating lymphocytes from pancreatic cancer lesions for cellular therapy
por: Meng, Qingda, et al.
Publicado: (2014)

Diversity of mutated antigen recognition by tumor infiltrating lymphocytes from patients with metastatic melanoma
por: Crystal, Jessica S, et al.
Publicado: (2015)

Effects of Ipilimumab on expanded tumor infiltrating lymphocytes in patients with stage IV malignant melanoma
por: Bjørn, Jon, et al.
Publicado: (2013)

Targeted testing for DNAI1 hot spot-mutation utilizing immunofluorescence microscopy findings
por: Szczepaniak, M, et al.
Publicado: (2012)

Phenotype, function and T cell receptor repertoire of tumor-infiltrating lymphocytes in patients with pancreatic ductal adenocarcinoma
por: Poschke, Isabel, et al.
Publicado: (2015)

Enhanced tumor-infiltrating lymphocytes (eTIL) for cellular therapy of patients with pancreatic cancer or glioblastoma
por: Meng, Qingda, et al.
Publicado: (2015)

Adoptive cell therapy with tumor infiltrating lymphocytes and intermediate dose IL-2 for metastatic melanoma
por: Andersen, Rikke, et al.
Publicado: (2014)

Positive cytoplasmic indirect immunofluorescence on HEp2 cells of unknown pattern: what to report to rheumatologists
por: Rotar, Z, et al.
Publicado: (2005)

OX40 and other immunoregulatory molecules are highly expressed on tumor infiltrating lymphocytes in oral, head and neck squamous cell carcinoma
por: Montler, Ryan, et al.
Publicado: (2014)

S76. Adoptive cell therapy of melanoma with autologous tumour infiltrating lymphocytes
por: Svane, I, et al.
Publicado: (2014)

Development of an adoptive cell therapy protocol with tumor-infiltrating lymphocytes and intermediate-dose interleukin-2 therapy
por: Nguyen, Linh T, et al.
Publicado: (2013)

Identification of predictive biomarker signatures in melanoma tumors associated with response to tumor-infiltrating lymphocyte (TIL) therapy
por: Chen, Jie Qing, et al.
Publicado: (2013)

Unique changes in the TCR repertoire of tumor-infiltrating lymphocytes underlie the synergy of radiotherapy with CTLA-4 blockade
por: Pilones, Karsten, et al.
Publicado: (2014)

Immunofluorescence microscopy (IFM) analysis of primary ciliary dyskinesia (PCD) patients with suspected inner dynein arm defects (IDA)
por: Hjeij, R, et al.
Publicado: (2012)

Challenges and Opportunities in the Statistical Analysis of Multiplex Immunofluorescence Data
por: Wilson, Christopher M., et al.
Publicado: (2021)

Development and validation of a Multiplex Real-Time PCR for HTLV-1/2 confirmatory diagnosis
por: Rocha Júnior, Maurício Cristiano, et al.
Publicado: (2014)

Predictive immune biomarker signatures in the tumor microenvironment of melanoma metastases associated with tumor-infiltrating lymphocyte (TIL) therapy
por: Chen, Jieqing, et al.
Publicado: (2014)

Towards multiplexed immunofluorescence of 3D tissues
por: Cho, Wonjin, et al.
Publicado: (2023)

You can run but you can't hide: tracking T cells in metastatic melanoma patients treated with tumor-infiltrating lymphocytes
por: Haymaker, Cara, et al.
Publicado: (2015)

Extent and location of tumor infiltrating lymphocytes in microsatellite stable colon cancer predict outcome to adjuvant active specific immunotherapy
por: Turksma, Annelies, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_f4t5epq1o4st1ig26qdmmrf954